Document Detail


Vasculoprotective effects of oestrogens.
MedLine Citation:
PMID:  11903309     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
1. The rationale for preclinical research on the atheroprotective effect of oestrogens is based on the epidemiological evidence that women are protected against the clinical complications of atherosclerosis until menopause. However, this protection, probably due to sex hormones, is progressively lost within the years following menopause. 2. In addition, numerous studies have clearly demonstrated the atheroprotective effect of oestrogens in all animal models. 3. In the present paper, we first summarize our understanding of the pathophysiology of atherosclerosis. We then focus on the recognized target of oestradiol (E2) in the vessel wall: the classical target, namely the endothelium, and a recently characterized target, namely cells of the inflammatory-immune system. Finally, we discuss how unknown mechanisms in atherosclerosis could be responsible for the absence of effect of hormone-replacement therapy in the Heart and Estrogen/ progestin Replacement Study (HERS).
Authors:
J F Arnal; F Bayard
Related Documents :
16218479 - Role of antiheat shock protein 60 autoantibodies in atherosclerosis.
18827909 - The secretory phospholipase a2 group iia: a missing link between inflammation, activate...
12615689 - Phagocytosis and macrophage activation associated with hemorrhagic microvessels in huma...
20299739 - Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis.
18378239 - Inflammatory and non-invasive vascular markers: the multimarker approach for risk strat...
4015749 - Increased atherosclerosis in rabbits immunized with endothelial cells.
17712479 - Nfat2 is implicated in corticosterone-induced rat leydig cell apoptosis.
23708119 - Nontransformed, gm-csf-dependent macrophage lines are a unique model to study tissue ma...
22816079 - Activity of the inflammatory process in different types of unstable atherosclerotic pla...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical and experimental pharmacology & physiology     Volume:  28     ISSN:  0305-1870     ISO Abbreviation:  Clin. Exp. Pharmacol. Physiol.     Publication Date:  2001 Dec 
Date Detail:
Created Date:  2002-03-20     Completed Date:  2002-08-23     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0425076     Medline TA:  Clin Exp Pharmacol Physiol     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  1032-4     Citation Subset:  IM    
Affiliation:
INSERM U397 et Laboratoire de Physiologie, CHU Rangueil, Toulouse, France. arnal@rangueil.inserm.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arteriosclerosis / drug therapy,  physiopathology*
Endothelium, Vascular / drug effects*,  physiology
Estrogen Replacement Therapy
Estrogens / pharmacology*,  therapeutic use
Female
Humans
Postmenopause / physiology
Chemical
Reg. No./Substance:
0/Estrogens

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of arterial smooth muscle tone and geometry in the regulation of peripheral conduit artery mech...
Next Document:  'Slow pressor' hypertension from low-dose chronic angiotensin II infusion.